BRIEF-Abeona Therapeutics receives FDA orphan drug designation for ABO-201 juvenile Batten disease gene therapy program
* Abeona Therapeutics receives FDA orphan drug designation for ABO-201 juvenile Batten disease gene therapy program
Jan 4 Mission Ready Services Inc :
* Mission Ready announces private placement & provides Wild Things acquisition update
* Mission Ready Services - non-brokered private placement of up to 11 million units at $0.10 per unit for gross proceeds of up to CDN $1.100 million
* Mission Ready Services - proceeds from offering to be used for growth of co's current initiatives, including manufacturing equipment, materials Source text for Eikon: Further company coverage:
NAIROBI, June 29 Kenya has delayed plans to start crude oil production and exports until the government passes an amended law that includes setting out how revenues will be shared between national and county government and local communities.